EN
HI
Emcure Pharmaceuticals share price chart
Emcure Pharmaceuticals Share Key Metrics
Volume
2.14 L
Market Cap
38113.98 CR
LTQ@LTP
31@2009.60
ATP
2013.13
Var Margin
16.67 %
Circuit Range
1798.9-2198.5
Delivery %
55.8 %
Value
43.10 CR
ASM/GSM
No
Market Lot
1
Summary
EMCURE stock price is ₹2009.6 as of 13 Aug, 2026. The stock intraday movement has stayed between ₹1983.30 and ₹2023.00, while Emcure Pharmaceuticals share price 52 week high low is ₹1260.00 & ₹2048.00.
In terms of trading activity, EMCURE share price has recorded a volume of 2,14,106 shares. The Emcure Pharmaceuticals has a market cap of ₹189659547. The stock’s Average Traded Price (ATP) stands at ₹2013.13, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 31 @ ₹2009.60.
The Emcure Pharmaceuticals upper circuit limit is ₹2198.50 & The Emcure Pharmaceuticals lower circuit limit is ₹1798.90, with a Value of ₹43.10 CR. The Delivery Percentage for the day is 55.8%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Emcure Pharmaceuticals Fundamentals
P/E Ratio
37.46
P/B Ratio
7.23
Div. Yield
0.18
Sector P/E
65.02
Sector P/B
3.32
Sec. Div. Yield
0.51
Emcure Pharmaceuticals Resistance and Support
Pivot 2002.87
Resistance
First Resistance
2020.74
Second Resistance
2042.77
Third Resistance
2060.64
Support
First Support
1980.84
Second Support
1962.97
Third Support
1940.94
Emcure Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 12 2026 | 2008.6 | 2009.6 | 0.55% | 2023 | 1983.3 |
| Tue Aug 11 2026 | 1995.19 | 1998.69 | 0.18% | 2024.9 | 1985 |
| Mon Aug 10 2026 | 2000 | 1995.19 | 0.85% | 2048 | 1967 |
Emcure Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals News
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Emcure Pharmaceuticals released the transcript of its Q1 FY27 earnings call, highlighting robust financial performance with revenue increasing 22.8% to Rs.2,580 crore and profit after tax growing 36.2% to Rs.292 crore. The company projects low to mid-teen revenue growth and 70-100 bps EBITDA margin expansion for FY27.
Aug 12 2026 18:35:05
Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Emcure Pharmaceuticals' Sanand formulations facility has received a "Voluntary Action Indicated (VAI)" classification from the USFDA following an inspection from May 6 to May 15, 2026. This classification signifies minor observations that do not require official regulatory action, and the inspection is now closed.
Aug 08 2026 10:20:03
Read More
Emcure Pharmaceuticals Management
| Name | Position |
|---|---|
| Berjis Desai | Chairman |
| Satish Mehta | Managing Director & Chief Executive Officer |
Emcure Pharmaceuticals Similar Stocks
Gland Pharma Ltd.
2891.20
-33.20 (1.14%)
Ajanta Pharma Ltd.
3541.00
34.00 (0.97%)
Ipca Laboratories Ltd.
1766.60
18.20 (1.04%)
Global Health Ltd.
1393.50
-46.90 (3.26%)
Narayana Hrudayalaya Ltd.
1831.30
-17.50 (0.95%)
Krishna Institute of Medical Sciences Ltd
803.95
-9.10 (1.12%)
Dr. Lal Pathlabs Ltd.
1953.30
3.40 (0.17%)
Wockhardt Ltd.
1847.40
-62.00 (3.25%)
Emcure Pharmaceuticals FAQs
The Buying Price of Emcure Pharmaceuticals share is 2009.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Emcure Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emcure Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Emcure Pharmaceuticals shares is 37.46. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Emcure Pharmaceuticals shares is 7.23. Useful to assess the stock's value relative to its book value.
To assess Emcure Pharmaceuticals’s valuation compare Sector P/E, P/B which are 65.02 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Emcure Pharmaceuticals is 38113.98 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Emcure Pharmaceuticals share price is 2048.00 & 1260.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Emcure Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
